Preview

Колопроктология

Расширенный поиск

CLOSTRIDIUM DIFFICILE ИНФЕКЦИЯ: КЛИНИКА, ДИАГНОСТИКА И ЛЕЧЕНИЕ (обзор литературы)

https://doi.org/10.33878/2073-7556-2017-0-2-80-88

Полный текст:

Об авторах

А. Л. Сафин
ФГБУ «ГНЦК им. А.Н. Рыжих» Минздрава России
Россия


С. И. Ачкасов
ФГБУ «ГНЦК им. А.Н. Рыжих» Минздрава России
Россия


М. А. Сухина
ФГБУ «ГНЦК им. А.Н. Рыжих» Минздрава России
Россия


О. И. Сушков
ФГБУ «ГНЦК им. А.Н. Рыжих» Минздрава России
Россия


Список литературы

1. Пилиев Д.В., Ачкасов С.И., Корнева Т.К. и соавт. Антибиотикоассоциированная диарея: современное состояние проблемы. Российский Журнал Гастроэнтерологии, Гепатологии Колопроктологии. - 2014. - №5. - с. 54-61.

2. Захаренко А.А., Суворов А.Н., Шлык И.В. и соавт. Нарушение микробиоциноза кишечника у больных колоректальным раком и способы их коррекции (обзор литературы). Колопроктология. - 2016. - №2 (56). - с. 48-56.

3. Маянский А.Н., Чеботарь И.В. Стафилококковые биопленки: структура, регуляция, отторжение. Журн. микробиол. - 2011. - №1. - с. 101-108.

4. Пикунов Д.Ю., Рыбаков Е.Г. и соавт. Псевдомембранозный колит (обзор литературы). Колопроктология. - 2010. - №2 (32). - с. 55-60.

5. Шелыгин Ю.А., Головенко А.О. и соавт. Трансплантация фекальной микробиоты - перспективы применения при заболеваниях кишечника (обзор литературы). Колопроктология. - 2015. -№4 (54). - с. 65-73.

6. Aguado J.M., Anttila V.J., Galperine T. et al. Highlighting clinical needs in Clostridium difficile infection: the views of European healthcare professionals at the front line. J. Hosp. Infect. - 2015. -90 (2): 117-125.

7. Ahmetagic S., Salkic N., Ahmetagic A. et al. Clostridium difficile infection in hospitalized patients at university clinical center tuzla, bosnia and herzegovina: a 4 year experience. Mater. Sociomed. - 2013. - AVICENA, d.o.o. 25 (3): 153-157.

8. Aquina C.T., Probst C.P., Becerra A.Z. et al. High Variability in Nosocomial Clostridium difficile Infection Rates Across Hospitals After Colorectal Resection. Dis. Colon Rectum. - 2016. - 59 (4): 323-331.

9. Blixt T., Gradel K.O., Homann C. et al. Asymptomatic carriers contribute to nosocomial Clostridium difficile infection: a cohort study of 4508 patients. Gastroenterology. - 2017.

10. Bomers M.K., Van Agtmael M.A., Luik H. et al. Using a dog’s superior olfactory sensitivity to identify Clostridium difficile in stools and patients: proof of principle study. BMJ. BMJ Group. - 2012. - 345: e7396.

11. Burnham C.-A.D., Carroll K.C. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin. Microbiol. Rev. American Society for Microbiology. - 2013. - 26 (3): 604-630.

12. Cohen S.H., Gerding D.N., Johnson S. et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect. Control Hosp. Epidemiol. Cambridge University Press. - 2010. - 31 (5): 431-455.

13. Dubberke E.R., Reske K.A., Noble-Wang J. et al. Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am. J. Infect. Control. - 2007. - 35 (5): 315-318.

14. Dupuy B., Sonenshein A.L. Regulated transcription of Clostridium difficile toxin genes. Mol. Microbiol. Blackwell Publishing Ltd. - 1998. - 27 (1): 107-120.

15. Durrani K.M., Gruhn J.G. Pseudomembranous enterocolitis. Am. J. Surg. - 1963. - 106 (6): 966-973.

16. Eiland E.H., Sawyer A.J., Massie N.L. et al. Fidaxomicin Use and Clinical Outcomes for Clostridium difficile-Associated Diarrhea. Infect. Dis. Clin. Pract. (Baltim. Md). Wolters Kluwer Health. -2015. - 23 (1): 32-35.

17. Guern R. Le, Wallet F. Diagnostic de l’infection à Clostridium difficile au laboratoire. Ann. Biol. Clin. (Paris). - 2013. - 71 (4): 395-400.

18. Guo S., Yan W., McDonough S.P., Lin N. et al. The recombinant Lactococcus lactis oral vaccine induces protection against C. difficile spore challenge in a mouse model. Vaccine. - 2015. - 33 (13): 1586-1595.

19. Hargreaves K.R., Clokie M.R.J. Clostridium difficile phages: still difficult? Front. Microbiol. - 2014. - 5: 184.

20. Hill K.A., Collins J., Wilson L. et al. Comparison of two selective media for the recovery of Clostridium difficile from environmental surfaces. J. Hosp. Infect. -2013. - 83 (2).

21. Huang J.S., Jiang Z.-D., Garey K.W. et al. Use of rifamycin drugs and development of infection by rifamycin-resistant strains of Clostridium difficile. Antimicrob. Agents Chemother. American Society for Microbiology. - 2013. - 57 (6): 2690-2693.

22. Johansson K., Karlsson H., Norén T. Clostridium difficile infection diagnostics - evaluation of the C. DIFF Quik Chek Complete assay, a rapid enzyme immunoassay for detection of toxigenic C. difficile in clinical stool samples. APMIS. - 2016. - 124 (11): 1016-1020.

23. Kachrimanidou M., Malisiovas N. Clostridium difficile infection: a comprehensive review. Crit. Rev. Microbiol. - 2011. - 37 (3): 178-187.

24. Kassam Z., Lee C.H., Yuan Y. et al. Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis. Am. J. Gastroenterol. - 2013. - 108 (4): 500-508.

25. Kazanowski M., Smolarek S., Kinnarney F. et al. Clostridium difficile: epidemiology, diagnostic and therapeutic possibilities - a systematic review. Tech. Coloproctol. Springer Milan. - 2014. - 18 (3): 223-232.

26. Kim J., Pai H., Seo M. et al. Epidemiology and Clinical Characteristics of Clostridium difficile Infection in a Korean Tertiary Hospital. J. Korean Med. Sci. - 2011. - 26 (10): 1258.

27. Kostakioti M., Hadjifrangiskou M., Hultgren S.J. Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harb. Perspect. Med. Cold Spring Harbor Laboratory Press. - 2013. - 3 (4): a010306.

28. Krutova M., Matejkova J., Tkadlec J. et al. Antibiotic profiling of Clostridium difficile ribotype 176--A multidrug resistant relative to C. difficile ribotype 027. Anaerobe. - 2015. - 36: 88-90.

29. Kundrapu S., Sunkesula V., Jury I. et al. A Randomized Trial of Soap and Water Hand Wash Versus Alcohol Hand Rub for Removal of Clostridium difficile Spores from Hands of Patients. Infect. Control Hosp. Epidemiol. - 2014. - 35 (2): 204-206.

30. Kyne L., Merry C., O’Connell B. et al. Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. Age Ageing. Oxford University Press. - 1999. - 28 (2): 107-113.

31. Kyne L., Warny M., Qamar A. et al. Asymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A. N. Engl. J. Med. Massachusetts Medical Society. 2000. - 342 (6): 390-397.

32. Landelle C., Verachten M., Legrand P. et al. Contamination of Healthcare Workers’ Hands with Clostridium difficile Spores after Caring for Patients with C. difficile Infection. Infect. Control Hosp. Epidemiol. - 2014. - 35 (1): 10-15.

33. Larson H.E., Parry J.V., Price A.B. et al. Undescribed toxin in pseudomembranous colitis. BMJ. - 1977. - 1 (6071).

34. LaSala P.R., Svensson A.M., Mohammad A.A. et al. Comparison of Analytical and Clinical Performance of Three Methods for Detection of Clostridium difficile. Arch. Pathol. Lab. Med. College of American Pathologist 325 Waukegan Rd, Northfield, IL 60093. -2012. - 136 (5): 527-531.

35. Levin J., Riley L.S., Parrish C. et al. The effect of portable pulsed xenon ultraviolet light after terminal cleaning on hospital-associated Clostridium difficile infection in a community hospital. Am. J. Infect. Control. - 2013. - 41 (8).

36. Locher H.H., Seiler P., Chen X. et al. In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infections. Antimicrob. Agents Chemother. American Society for Microbiology (ASM). - 2014. - 58 (2): 892-900.

37. McFarland L.V. Meta-Analysis of Probiotics for the Prevention of Antibiotic Associated Diarrhea and the Treatment of Clostridium difficile Disease. Am. J. Gastroenterol. Nature Publishing Group. - 2006. -101 (4): 812-822.

38. McFarland L.V., Surawicz C.M. Clostridium Difficile Associated Disease: Diagnosis and Treatment. Evidence-Based Gastroenterol. Hepatol. Oxford, UK. Wiley-Blackwell. - 2010. - 335-354.

39. Metan G., Türe Z., Kaynar L. et al. Tigecycline for the treatment of Clostridium difficile infection refractory to metronidazole in haematopoietic stem cell transplant recipients. J. Chemother. Taylor & Francis. - 2015. - 27 (6): 354-357.

40. Brien J.A., Lahue B.J., Caro J.J. et al. The Emerging Infectious Challenge Clostridium difficile-Associated Disease in Massachusetts Hospitals: Clinical and Economic Consequences. Infect. Control & Hosp. Epidemiol. Cambridge University Press. 2007. - 28 (11): 1219-1227.

41. Pichlo C., Montada A.A., Schacherl M. et al. Production, Crystallization and Structure Determination ofC. difficile PPEP-1 via Microseeding and Zinc-SAD. J. Vis. Exp. - 2016. - (118): e55022-e55022.

42. Planche T.D., Davies K.A., Coen P.G. et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect. Dis. - 2013. - 13 (11): 936-945.

43. Putsathit P., Morgan J., Bradford D. et al. Evaluation of the BD Max Cdiff assay for the detection of toxigenic Clostridium difficile in human stool specimens. Pathology. 2015. - 47 (2): 165-168.

44. Reveles K.R., Lee G.C., Boyd N.K. et al. The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010. Am. J. Infect. Control. - 2014. - 42 (10): 1028-1032.

45. Shah D.N., Aitken S.L., Barragan L.F. et al. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study. J. Hosp. Infect. - 2016. -93 (3): 286-289.

46. Sinclair A., Xie X., Saab L. et al. Lactobacillus probiotics in the prevention of diarrhea associated with Clostridium difficile: a systematic review and Bayesian hierarchical meta-analysis. C. open. Canadian Medical Association. - 2016. - 4 (4): E706-E718.

47. Steindl G., Fiedler A., Huhulescu S. et al. Effect of airborne hydrogen peroxide on spores of Clostridium ŒOSTRIDIUM DIFFICILE ИНФЕКЦИЯ: КЛИНИКА, ДИАГНОСТИКА И ЛЕЧЕНИЕ (обзор литературы) difficile. Wien. Klin. Wochenschr. Springer Vienna. - 2015. - 127 (11-12): 421-426.

48. Surawicz C.M., Brandt L.J., Binion D.G. et al. Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections. Am. J. Gastroenterol. Nature Publishing Group. 2013. - 108 (4): 478-498.

49. Surawicz C.M., Brandt L.J., Binion D.G. et al. Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections. Am. J. Gastroenterol. Nature Publishing Group. - 2013. - 108 (4): 478-498.

50. Vardakas K.Z., Polyzos K.A., Patouni K. et al. Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. Int. J. Antimicrob. Agents. 2012. - 40 (1): 1-8.

51. Verity P., Wilcox M.H., Fawley W. et al. Prospective evaluation of environmental contamination by Clostridium difficile in isolation side rooms. J. Hosp. Infect. Elsevier. 2001. - 49 (3): 204-209.

52. Vesoulis Z., Williams G., Matthews B. Pseudomembranous enteritis after proctocolectomy. Dis. Colon Rectum. Springer-Verlag. - 2000. - 43 (4): 551-554.


Для цитирования:


Сафин А.Л., Ачкасов С.И., Сухина М.А., Сушков О.И. CLOSTRIDIUM DIFFICILE ИНФЕКЦИЯ: КЛИНИКА, ДИАГНОСТИКА И ЛЕЧЕНИЕ (обзор литературы). Колопроктология. 2017;(2):80-88. https://doi.org/10.33878/2073-7556-2017-0-2-80-88

For citation:


Safin A.L., Achkasov S.I., Sukhina M.A., Sushkov O.I. QOSTRIDIUM DIFFICILE INFECTION: QINIC, DIAGNOSTICS AND TREATMENT (review). Koloproktologia. 2017;(2):80-88. (In Russ.) https://doi.org/10.33878/2073-7556-2017-0-2-80-88

Просмотров: 253


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2073-7556 (Print)
ISSN 2686-7303 (Online)